RxSight's (RXST) shares were up more than 13% in recent Monday trading after Wells Fargo upgraded the company's stock to overweight from equalweight and raised its price target to $25 from $17.
Trading volume stood at over 1.1 million shares against a daily average of roughly 1 million.
Price: 16.08, Change: +1.89, Percent Change: +13.28